Izradite svoj profil
Citirano
Sve | Od 2019. | |
---|---|---|
Citati | 7324 | 7312 |
H-indeks | 13 | 13 |
i10-indeks | 14 | 14 |
Javni pristup
Prikaži sve17 članaka
0 članaka
dostupno
nije dostupno
Na temelju uvjeta financiranja
Suautori
- Xiaole Shirley LiuCEO, GV20 TherapeuticsPotvrđena adresa e-pošte na ds.dfci.harvard.edu
- Shengqing (Stan) GuThe University of Texas MD Anderson Cancer CenterPotvrđena adresa e-pošte na mdanderson.org
- Bo LiAssociate Professor, University of PennsylvaniaPotvrđena adresa e-pošte na chop.edu
- Peng JiangStadtman Tenure-Track Investigator, National Cancer Institute, NIHPotvrđena adresa e-pošte na nih.gov
- Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolPotvrđena adresa e-pošte na dfci.harvard.edu
- Xihao HuGV20 TherapeuticsPotvrđena adresa e-pošte na gv20therapeutics.com
- Kai WucherpfennigPotvrđena adresa e-pošte na dfci.harvard.edu
- Avinash SahuUniversity of New Mexico Cancer Center & TumorAI.orgPotvrđena adresa e-pošte na salud.unm.edu
- Taiwen LiAssociate Professor, West China Hospital of Stomatology, Sichuan UniversityPotvrđena adresa e-pošte na scu.edu.cn
- Jian ZhangAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityPotvrđena adresa e-pošte na tju.edu.cn
- Eliezer Van AllenDana-Farber Cancer InstitutePotvrđena adresa e-pošte na dfci.harvard.edu
Prati
Jingxin Fu
Research Scientist, Medical Oncology Department, Dana-Farber Cancer Institute
Potvrđena adresa e-pošte na ds.dfci.harvard.edu - Početna stranica